Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1979 Apr;41(4):452–455. doi: 10.1136/hrt.41.4.452

QT time in patients treated with alprenolol or placebo after myocardial infarction.

G Nyberg, A Vedin, C Wilhelmsson
PMCID: PMC514695  PMID: 380606

Abstract

Studies were made on the effects of long-term beta-blockade on the QT interval in patients discharged alive from hospital after myocardial infarction. The patients (n = 230) in this study constituted all those who participated in the alprenolol study on postmyocardial patients in Göteborg, Sweden. The study was double-blind (alprenolol 200 mg b.i.d. or placebo) and randomised. The patients were divided into 4 risk groups (1-4) with different predicted mortality. The electrocardiograms before and after 8 weeks of treatment were analysed with respect to heart rate and QT time. There was a decrease in heart rate of about 10% in the alprenolol treated patients. The QT time was not significantly influenced by alprenolol. The rate corrected QT time (QTc) decreased in the subgroup of the most severely diseased patients (subgroup 4) treated with alprenolol.

Full text

PDF
452

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. LeWinter M. M., Crawford M. H., O'Rourke R. A., Karliner J. S. The effects of oral propranolol, digoxin and combination therapy on the resting and exercise electrocardiogram. Am Heart J. 1977 Feb;93(2):202–209. doi: 10.1016/s0002-8703(77)80312-8. [DOI] [PubMed] [Google Scholar]
  2. Moss A. J., McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971 Oct 14;285(16):903–904. doi: 10.1056/NEJM197110142851607. [DOI] [PubMed] [Google Scholar]
  3. Raine A. E., Pickering T. G. Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade. Br Med J. 1977 Jul 9;2(6079):90–92. doi: 10.1136/bmj.2.6079.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Raine A. E., Williams E. M. Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction. Br Heart J. 1976 Aug;38(8):873–874. [PubMed] [Google Scholar]
  5. Schwartz P. J., Snebold N. G., Brown A. M. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976 Jun;37(7):1034–1040. doi: 10.1016/0002-9149(76)90420-3. [DOI] [PubMed] [Google Scholar]
  6. Seides S. F., Josephson M. E., Batsford W. P., Weisfogel G. M., Lau S. H., Damato A. N. The electrophysiology of propranolol in man. Am Heart J. 1974 Dec;88(6):733–741. doi: 10.1016/0002-8703(74)90283-x. [DOI] [PubMed] [Google Scholar]
  7. Stern S., Eisenberg S. The effect of propranolol (Inderal) on the electrocardiogram of normal subjects. Am Heart J. 1969 Feb;77(2):192–195. doi: 10.1016/0002-8703(69)90350-0. [DOI] [PubMed] [Google Scholar]
  8. Vedin A., Wilhelmsen L., Wedel H., Pettersson B., Wilhelmsson C., Elmfeldt D., Tibblin G. Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarction. Acta Med Scand. 1977;201(4):309–316. doi: 10.1111/j.0954-6820.1977.tb15705.x. [DOI] [PubMed] [Google Scholar]
  9. Vedin A., Wilhelmson C. Angina pectoris, hypertension, decompensation and return to work during two years' follow-up. Acta Med Scand Suppl. 1975;575:25–30. doi: 10.1111/j.0954-6820.1975.tb06482.x. [DOI] [PubMed] [Google Scholar]
  10. Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES